The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance
Open accessAbstract
Background— Cardiac complications secondary to iron overload are the leading cause of death in β-thalassemia major. Approximately two thirds of patients maintained on the parenteral iron chelator deferoxamine have myocardial iron loading. The oral iron chelator deferiprone has been demonstrated to remove myocardial iron, and it has been proposed that in combination with deferoxamine it may have additional effect. Methods and Results— Myocardial iron loading was assessed with the use of myocardial T2* cardiovascular magnetic resonance in 167 patients with thalassemia major receiving standard maintenance chelation monotherapy with subcutaneous deferoxamine. Of these patients, 65 with mild to moderate myocardial iron loading (T2* 8 to 20 ms) entered the trial with continuation of subcutaneous deferoxamine and were randomized to receive additional oral placebo (deferoxamine group) or oral deferiprone 75 mg/kg per day (combined group). The primary end point was the change in myocardial T2* over 12 months. Secondary end points of endothelial function (flow-mediated dilatation of the brachial artery) and cardiac function were also measured with cardiovascular magnetic resonance. There were significant improvements in the combined treatment group compared with the deferoxamine group in myocardial T2* (ratio of change in geometric means 1.50 versus 1.24; P =0.02), absolute left ventricular ejection fraction (2.6% versus 0.6%; P =0.05), and absolute endothelial function (8.8% versus 3.3%; P =0.02). There was also a significantly greater improvement in serum ferritin in the combined group (−976 versus −233 μg/L; P <0.001). Conclusions— In comparison to the standard chelation monotherapy of deferoxamine, combination treatment with additional deferiprone reduced myocardial iron and improved the ejection fraction and endothelial function in thalassemia major patients with mild to moderate cardiac iron loading.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Borgna‐Pignatti, C., Rugolotto, S., Stefano, P. D., Zhao, H., Cappellini, M. D., Vecchio, G. C. D., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., et al. (2004) · PubMed · Cited by 1,119
Survival in Medically Treated Patients with Homozygous β-Thalassemia
Olivieri, N. F., Nathan, D. G., MacMillan, J. H., Wayne, A. S., Liu, P. P., McGee, A., Martin, M., Koren, G., & Cohen, A. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310903 · Cited by 852
Maceira, A., Prasad, S., Khan, M., & Pennell, D. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600572889 · Cited by 847
Self-citationBrittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310902 · Cited by 829
Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register
Modell, B., Khan, M., & Darlison, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02357-6 · Cited by 583
Pennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
Self-citationAnderson, L. J., Wonke, B., Prescott, E., Holden, S., Malcolm Walker, J., & Pennell, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09740-4 · Cited by 430
Self-citationLong-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major
Olivieri, N. F., Brittenham, G. M., McLaren, C. E., Templeton, D. M., Cameron, R. G., McClelland, R. A., Burt, A. D., & Fleming, K. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390701 · Cited by 420
Anderson, L. J., Westwood, M. A., Holden, S., Davis, B., Prescott, E., Wonke, B., Porter, J. B., Malcolm Walker, J., & Pennell, D. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05202.x · Cited by 414
Self-citationWestwood, M., Anderson, L. J., Firmin, D. N., Gatehouse, P. D., Charrier, C. C., Wonke, B., & Pennell, D. J. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10332 · Cited by 379
Self-citationPractical management of iron overload
Porter, J. B. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03195.x · Cited by 378
Borgna-Pignatti, C. (2006) · Blood · doi:10.1182/blood-2005-07-2933 · Cited by 376
Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease
Wood, J. C., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2004) · Blood · doi:10.1182/blood-2003-06-1919 · Cited by 341
Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Duffy, S. J., Biegelsen, E. S., Holbrook, M., Russell, J. D., Gokce, N., Keaney, J. F., & Vita, J. A. (2001) · Circulation · doi:10.1161/01.cir.103.23.2799 · Cited by 271
Piga, A. G., Gaglioti, C. M., Fogliacco, E., & Tricta, F. (2003) · PubMed · Cited by 222
Combined therapy with deferiprone and desferrioxamine
Wonke, Wright, & Hoffbrand (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01002.x · Cited by 218
Wanless, I. R. (2002) · Blood · doi:10.1182/blood-2002-01-0306 · Cited by 175
Myocardial Iron Loading in Patients with Thalassemia Major on Deferoxamine Chelation
Tanner, M., Galanello, R., Dessi, C., Westwood, M., Smith, G., Nair, S., Anderson, L., Walker, J., & Pennell, D. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600698155 · Cited by 166
Self-citationArterial Stiffness and Endothelial Function in Patients With β-Thalassemia Major
Cheung, Y., Chan, G., & Ha, S. (2002) · Circulation · doi:10.1161/01.cir.0000037225.92759.a7 · Cited by 153
Combined therapy with deferiprone and desferrioxamine in thalassemia major.
Origa, R., Bina, P., Agus, A., Crobu, G., Defraia, E., Dessì, C., Leoni, G., Muroni, P. P., & Galanello, R. (2005) · PubMed · Cited by 145
Self-citationHeart failure in beta thalassemia: a 5-year follow-up study
Kremastinos, D. T. H., Tsetsos, G. A., Tsiapras, D. P., Karavolias, G., Ladis, V., & KATTAMIS, C. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00879-8 · Cited by 135
Global impairment of brachial, carotid, and aortic vascular function in young smokers
Wiesmann, F., Petersen, S. E., Leeson, P., Francis, J. M., Robson, M. D., Wang, Q., Choudhury, R. P., Channon, K. M., & Neubauer, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.033 · Cited by 120
Link, G., Konijn, A. M., Breuer, W. V., Cabantchik, Z. I., & Hershko, C. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.116487 · Cited by 110
Sørensen, M. B., Collins, P. D., Ong, P. J. L., Webb, C. M., Hayward, C., Asbury, E., Gatehouse, P. D., Elkington, A. G., Yang, G., Kubba, A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000030940.73167.4e · Cited by 92
Self-citationDaar, S., & Pathare, A. V. (2006) · Annals of Hematology · doi:10.1007/s00277-005-0075-z · Cited by 83
Parker, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21003 · Cited by 61
Caro, J. J., Huybrechts, K. F., & Green, T. C. (2002) · BMC Hematology · doi:10.1186/1471-2326-2-4 · Cited by 28
Cited by
Messroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0389-8 · Cited by 1,727
Galanello, R., & Origa, R. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-11 · Cited by 1,466
Self-citationBozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31822-6 · Cited by 807
Cao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722
Self-citation
Metadata
- Authors
- Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Roughton, M., Assomull, R., Nair, S. V., Walker, J. M., & Pennell, D. J.
- Venue
- Circulation
- Published
- 2007-04-10
- Volume
- 115
- Issue
- 14
- Pages
- 1876-1884
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2067697375
- Cited by
- 482
- References
- 29
- FWCI
- 20.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.